Child and Adolescent Psychiatry
Substance Use Disorder
Johns Hopkins Launches Center For Psychedelic Research
Researchers to use psychedelics to study the mind and identify therapies for diseases such as addiction, PTSD and Alzheimer’s
Released: September 4, 2019. A group of private donors has given $17 million to start the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine, making it what’s believed to be the first such research center in the U.S., and the largest research center of its kind in the world. In the absence of federal funding for such therapeutic research in people, the new center will rely on the gifts announced today to advance the emerging field of psychedelics for therapies and wellness.
Seeking Knowledge to Cure and Prevent
Our clinical research programs range from efficacy and treatment-response studies to clinical trials and epidemiology. Our basic research encompasses bioinformatics, genetics, neuroscience, neuroimaging, and molecular biology - all in an effort to unlock the causal pathways to the major psychiatric conditions and to use this knowledge to develop practical means to improve diagnosis and treatment.
The depth of our clinical expertise and the breadth of our research programs allow us to train the next generation of psychiatrists and scientists to be clinical and research leaders. Our educational programs include medical student education, a general psychiatry residency, a child and adolescent psychiatry residency, and post-doctoral fellowship and research training opportunities.Training Programs